Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

• DOI: 10.1111/hepr.13892
• Publication Date: 2023-02-24T15:18:54Z
• Authors: Kiyoshi Hasegawa; Nobuyuki Takemura; Tatsuya Yamashita; Takeyuki Watadani; Masaki Kaibori; Shoji Kubo; Mitsuo Shimada; Hiroaki Nagano; Etsuro Hatano; Hiroshi Aikata; Hiroko Iijima; Kazuomi Ueshima; Kazuyoshi Ohkawa; Takuya Genda; Kaoru Tsuchiya; Takuji Torimura; Masafumi Ikeda; Junji Furuse; Masaaki Akahane; Satoshi Kobayashi; Hideyuki Sakurai; Atsuya Takeda; Takamichi Murakami; Utaroh Motosugi; Yutaka Matsuyama; Masatoshi Kudo; Ryosuke Tateishi
• Keywords: Grading (engineering); Clinical Practice; Clinical Oncology

The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by Japan Society Hepatology, according to methodology evidence-based medicine and partly Grading Recommendations Assessment, Development Evaluation system, which published in October 2021 Japanese. In addition surveillance-diagnostic treatment algorithms, a new algorithm systemic therapy has been created, as multiple drugs hepatocellular carcinoma can be currently selected. Here, or algorithms evidence on recommendations are based described.